Indeed, patients with type 2 DM typically have high blood glucose, insulin and IGF1 levels, as NET cell proliferation in patients with DM could at least in part depend on extracellular growth factor-mediated stimulation of the insulin-receptor/IGF1R/PI3K/Akt/mTORC1 pathway [21]. This evidence concerns the gene IGF1 and diabetes mellitus.